Dermatology Consulting Services, High Point NC   Report issue

Academic/Hospital Phase 2 Phase 3 Phase 4
Founded: High Point NC United States

Organization Overview

First Clinical Trial
2009
NCT00987545
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2023

Timeline

NOW
  • Now

Alternative names

Dermatology Consulting Services, High Point NC | Dermatology Consulting Services, PLLC

Active Ingredients

Drugs in Phase 4 Trials (3)

clobetasol (dermovate) (1 trial)

halobetasol (ultravate) (2 trials)

tazarotene (tazorac) (2 trials)

Drugs in Phase 3 Trials (1)

brimonidine (alphagan) (2 trials)

Drugs in Phase 2 Trials (2)

qax-576 (1 trial)

roflumilast (daliresp) (1 trial)

Drugs in Other Trials (1)

gel (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Erythema (Phase 3)

Keloid (Phase 2)

Recurrence (Phase 2)

Rosacea (Phase 3)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 7
  • # of Trial APIs: 7